StockData
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31

BIOHARVEST SCIENCES INC.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.80−0.05 (-2.70%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Bioharvest Sciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Bioharvest Sciences filed with the SEC